Amanote Research
Register
Sign In
Second RNAi Drug Approved
Nature Biotechnology
- United Kingdom
doi 10.1038/s41587-020-0494-3
Full Text
Open PDF
Abstract
Available in
full text
Categories
Applied Microbiology
Biotechnology
Biomedical Engineering
Molecular Medicine
Bioengineering
Date
April 1, 2020
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Second RNAi Pathway Emerges
Genome Biology
From the FDA: Epilepsy Drug Approved
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
New Drug Approved for Age Related Macular Degeneration
BMJ
RNAi-based Small Molecule Repositioning Reveals Clinically Approved Urea-Based Kinase Inhibitors as Broadly Active Antivirals
PLoS Pathogens
Immunology
Molecular Biology
Virology
Microbiology
Parasitology
Genetics
Variability of State-Approved Emergency Medical Services Drug Formularies
Prehospital and Disaster Medicine
Emergency Nursing
Emergency Medicine
Application of RNAi to Genomic Drug Target Validation in Schistosomes
PLoS Neglected Tropical Diseases
Pharmacology
Public Health
Environmental
Toxicology
Infectious Diseases
Pharmaceutics
Occupational Health
Cannabidiol Drug Approved for Use in Two Forms of Epilepsy
Pharmacy Today
Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis
NeuroPharmac Journal
Stiripentol: New Approved Drug for the Dravet Syndrome: Pharmacotherapeutics Review
NeuroPharmac Journal
